查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1873996

生物技术市场

Biotechnology Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

2024 年生物技术市场价值约为 4,271.7 亿美元，预计到 2031 年将达到 9,666.8 亿美元，在此期间的年复合成长率(CAGR) 为 12.6%。

生物技术广泛应用于工业生物加工、生物资讯学、食品与农业、医疗保健、自然资源管理和环境保护等许多领域。现代生物技术透过促进先进产品和技术的研发，推动创新，致力于攻克罕见疾病和疑难杂症，同时透过减少环境影响和增强粮食安全，促进永续发展。

此外，生物技术有助于实现更清洁、更节能的工业製造流程。推动市场发展的关键因素包括基因组定序成本的下降、技术的快速进步以及来自公共和私营部门的大力支持。行业会议和研讨会数量的增加表明，人们对该领域的兴趣和投资正在不断增长，这凸显了可能影响未来持续增长的重要市场趋势。

生物技术市场分析

基因组定序成本的大幅下降是推动临床遗传学发展的主要动力，它改变了罕见疾病的诊断和治疗方式，并加速了精准医疗的普及。人类基因组定序的成本已从2007年的约100万美元骤降至2014年的1,000美元，目前约为600美元。

基因组定序成本的大幅降低使得定序更加普及，成为生技市场的主要成长动力。此外，製药和生物製药公司对基因组技术的日益广泛应用也进一步推动了市场成长，因为这些公司利用定序资料进行药物研发、标靶治疗和个人化治疗策略。

生物技术市场概览

资讯学和生物学领域的专家越来越多地利用先进的定序技术来产生更准确、更全面的基因组资料。近年来，DNA组装软体和染色体序列定位创新技术取得了显着进步，从而增强了基因组研究能力。

为了促进这些新兴技术的应用，多项策略措施已经启动。例如，美国国家人类基因组研究所（NHGRI）于1989年启动了基因组定序计划，旨在掌握基因组学领域不断发展的机会。同时，基因组技术计画正积极推动下一代工具和仪器的研发，以促进快速、经济高效的DNA定序、功能基因组学实验和SNP基因分型。该计划还有助于技术从研发者向最终用户转移，鼓励学术界和产业界研究机构之间的多学科合作。

市场也经历了产业参与者的创新浪潮。太平洋生物科学公司（Sequel）和牛津奈米孔技术公司（PromethION）等公司推出了最先进的下一代定序（NGS）平台。同时，罗氏GS FLX（454）、Illumina HiSeq 2000（Solexa）和AB SOLiD（Agencourt）等系统持续占据市场主导地位。这些技术进步显着提高了基因组定序的速度、准确性和经济性。

因此，定序技术的不断创新预计将成为预测期内生物技术市场快速成长的关键驱动力。

全球生物技术市场按地区划分为北美、欧洲、亚太、中东和非洲以及南美和中美洲。北美，尤其是美国，是最大的生物技术市场。该地区的成长特点是：对生物製药和生物技术公司创新产品的需求不断增长，主要市场参与者的存在，以及许多学术和研究机构投入的大量研发资源。此外，持续的技术进步预计将进​​一步刺激北美市场的成长。

战略洞察

生物技术市场驱动因素与机会

医疗保健领域对先进方法的日益重视将惠及美国市场

北美生技市场正经历快速成长，这主要得益于先进技术在医疗保健领域的整合、对精准医疗日益增长的关注，以及公共和私营部门对基因组研究的大量投资。该地区已成为生物技术创新中心，这得益于旨在变革医疗服务模式、提高农业生产力和提升工业生物製造能力的合作努力。精准医疗是当代医疗保健领域最具变革性的趋势之一，在美国和加拿大正获得显着发展。政府支持的各项倡议，以及创投和机构资金，正在推动基因组学、标靶治疗和个人化诊断的研究。这种高度重视正在重塑临床实践，并为疗效更佳、副作用更少的客製化治疗方案铺平道路。

由于研究项目的不断发展和商业模式的调整，医疗和农业生物技术都取得了显着进展。 CRISPR、合成生物学和分子诊断等生物工程工具正被用于创造新型生物分子、增强作物抗病性以及开发新一代治疗产品。值得注意的是，2022年，美国卫生与公众服务部（HHS）拨款4000万美元，用于加强活性药物成分（API）、抗生素以及生产关键药物和提升疫情应对能力所需的重要原材料的生物製造能力。这项投资旨在解决关键供应链的脆弱性，并支持药品生产回流国内。同时，美国国防部（DoD）启动了「三军生物技术辅助韧性供应链」计划，该计划将在五年内获得超过2.7亿美元的资金支持。这项雄心勃勃的计画旨在透过开发可持续燃料、高性能材料、聚合物、树脂和防护装备等对国家安全和韧性至关重要的要素，加速生物基创新成果的商业化，尤其是在国防领域。

这些发展得益于波士顿、旧金山和多伦多等城市中生物技术公司、学术机构和创新集群的蓬勃发展。强大的智慧财产权框架、先进的研究基础设施和高素质的劳动力也提升了该地区的全球竞争力。总而言之，在战略投资、前沿创新和旨在增强医疗保健和产业韧性的政府倡议的推动下，北美生物技术市场有望实现持续成长。预计在预测期内，这种充满活力的环境将释放巨大的经济价值，并巩固该地区在全球生物技术领域的领先地位。

政府措施—生物技术市场的机会

2023 年 12 月，生物技术部 (DBT) 和生物技术产业研究援助委员会 (BIRAC) 在新德里 Pragati Maidan 的 Bharat Mandapam 举办的第三届全球生物印度展 (Global Bio-India) 上宣布推出 14 种由新创公司和企业家工业开发的新型生物技术产品，涵盖医疗保健、诊断、医疗保健、农业保健、诊断、医疗保健和企业家工业开发的新型生物技术产品，涵盖医疗保健、诊断、医疗、农业保健全球生物印度展是重要的国际生物技术盛会。

近年来这些进展有望为生物技术市场创造有吸引力的成长机会。

生物技术市场报告細項分析

生物技术市场分析的关键组成部分包括产品和应用。

依产品划分，生物技术市场可分为DNA定序、发酵、细胞分析、奈米生物技术、色谱法、PCR技术、组织工程与再生等技术。 2023年，DNA定序占据最大的市场份额，预计在预测期内将保持最高的成长速度。 DNA定序是确定DNA链中核苷酸碱基确切顺序的关键技术。它已成为基础研究和应用研究的必备工具，并在医疗保健、生物技术、农业和法医学等领域有着广泛的应用。

DNA定序技术最早的大规模应用之一是人类基因组计划，该计划历时十三年，大大增进了我们对与遗传疾病相关的基因突变的理解。如今，DNA定序技术使研究人员能够识别与遗传疾病相关的特定基因，有助于开发标靶疗法和个人化医疗。

除了医疗保健领域，DNA定序也广泛应用于亲子鑑定和亲缘关係分析等基因检测。它在法医学中也发挥着至关重要的作用，有助于识别犯罪嫌疑人和受害者。在环境领域，DNA定序有助于分析造成空气、水和食物污染的细菌和其他微生物。

此外，这项技术在农业研究中至关重要，它使科学家能够研究动植物物种的遗传变异和迁移模式。这些资讯对于识别稀有品种以及优化种子和牲畜培育至关重要。

整体而言，DNA定序的多功能性和影响力持续推动着各领域的创新和投资。

包括赛默飞世尔科技公司、默克集团、Illumina公司以及众多新创公司在内的多家公司，提供用于DNA定序技术的各种试剂盒和试剂。因此，DNA定序及其应用带来的许多益处预计将在预测期内显着推动该领域的成长。

依应用领域划分，生物技术市场可分为工业加工、生物资讯学、食品与农业、健康、自然资源与环境等应用。 2023年，工业加工领域占据最大的市场份额，而生物资讯领域预计在预测期内将以更快的速度成长。工业加工或生物加工市场是生物技术领域最具发展前景的领域之一，对医疗保健和农业生物技术产生了重大影响，并为污染防治和资源保​​护提供了一种新方法。工业加工或生物加工市场能够降低企业成本，创造新市场，同时最大限度地减少对环境的破坏。大多数的生物技术实验室研究都是为了商业应用而进行。这些应用被用于药物发现和开发。人类蛋白质的治疗药物是透过重组方法开发的。例如，重组人类胰岛素是基因泰克公司于1982年生产和销售的首个重组药物。糖尿病盛行率的上升为重组胰岛素带来了丰厚的利润，并推动了生物技术市场未来的显着成长。此外，工业加工应用包括生产酵素和微生物，以在化学品、食品配料、洗涤剂、纸张、纺织品、饮料、织物、塑胶、个人护理、生物燃料等行业中创造生物基产品。

按地域分類的生物技术市场份额分析

生物技术市场报告的地理范围主要分为五个区域：北美、亚太、欧洲、中东和非洲以及南美和中美洲。

亚太地区被公认为全球生技市场成长最快的地区。预计该地区的市场，尤其是中国、日本和印度等国家，将经历显着成长。这一成长归功于市场参与者对发展中经济体日益增长的关注以及政府的支持性政策。

生物技术市场报告范围

生物技术市场新闻及最新动态

生物技术市场评估是透过收集定性和定量资料，结合一手和二手研究方法进行的，其中包括重要的企业出版物、协会资料和资料库。以下列出了生物技术市场的最新发展和策略：

  • 2022年4月，CytoTronics获得925万美元的种子轮融资，由Anzu Partners领投，Milad Alucozai（BoxOne Ventures）及其他机构投资者参与。该公司利用这笔种子轮融资来推进其创新平台的发展，该平台采用电脑晶片技术进行基于细胞的电学和电化学分析。 （资料来源：CytoTronics，新闻稿，2022）

生物技术市场报告涵盖范围和成果

《生物技术市场规模及预测（2022-2030）》报告对市场进行了全面分析，涵盖以下领域：

  • 涵盖范围内所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态，例如驱动因素、限制因素和关键机会
  • 未来主要趋势
  • 详细的PEST/波特五力模型与SWOT分析
  • 全球及区域市场分析，涵盖关键市场趋势、主要参与者、法规及近期市场发展动态。
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展动态
  • 公司详细概况

目录

第一章：引言

第二章：全球生物技术市场－主要结论

第三章：全球生技市场－市场概况

  • 概述
  • 市场区隔
    • 全球生物技术市场—依技术分类
    • 全球生技市场－按应用领域划分
    • 全球生物技术市场－按地域划分
  • 害虫分析
    • 北美 - PEST 分析
    • 欧洲 - PEST 分析
    • 亚太地区 - PEST 分析
    • 中东和非洲 - PEST 分析
    • 南美洲和中美洲—PEST分析

第四章：全球生技市场－主要市场动态

  • 关键市场驱动因素
    • 基因组定序价格下降
    • 增加创新技术
    • 私营和政府机构的倡议日益增多
  • 主要市场限制因素
    • 与基因数据相关的风险
    • 基因改造作物的系统性风险
  • 主要市场机会
    • NSG在生物标记发现与精准医学的应用
  • 未来趋势
    • 未来崛起会议与研讨会
  • 影响分析

第五章：生技市场－全球分析

  • 全球生物技术市场收入预测与分析
  • 全球生技市场（依地域划分）－预测与分析
  • 市场定位
  • 关键球员表现
    • 赛默飞世尔科技公司 5.4.2 丹纳赫
  • 专家意见

第六章：全球生物技术市场分析－依技术划分

  • 概述
  • DNA定序市场
  • 发酵市场
  • 细胞检测市场
  • 奈米生物技术市场
  • 色谱市场
  • PCR技术市场
  • 组织工程与再生市场
  • 其他市场

第七章：全球生物技术市场分析－按应用领域划分

  • 概述
  • 工业/生物加工市场
  • 生物资讯市场
  • 食品和农业市场
  • 健康市场
  • 自然资源与环境市场
  • 其他市场

第八章：北美生技市场营收及至2025年的预测

  • 概述
  • 北美生物技术市场收入及至2025年预测
  • 北美生物技术市场收入及预测（按技术划分）
  • 北美生物技术市场收入及预测（按应用领域划分）
  • 北美生物技术市场收入及至2025年预测（按国家/地区划分）(%)
  • 美国生物技术市场收入及至2025年预测
    • 美国生物技术市场收入及至2025年预测
    • 美国生物技术市场收入及至2025年预测（依技术分类）
    • 美国生物技术市场收入及至2025年预测（按应用领域划分）
  • 加拿大生物技术市场收入及至2025年的预测
    • 加拿大生物技术市场收入及至2025年预测
    • 加拿大生物技术市场收入及至2025年预测（依技术分类）
    • 加拿大生物技术市场收入及至2025年预测（依应用领域划分）
  • 墨西哥生物技术市场收入及至2025年预测
    • 墨西哥生物技术市场收入及至2025年预测
    • 墨西哥生物技术市场收入及至2025年预测（依技术分类）
    • 墨西哥生物技术市场收入及至2025年预测（按应用领域划分）

第九章：欧洲生技市场收入及至2025年的预测

  • 概述
  • 欧洲生物技术市场收入及至2025年预测
  • 欧洲生物技术市场收入及预测（依技术分类）
  • 欧洲生物技术市场收入及预测（按应用领域划分）
  • 欧洲生物技术市场收入及至2025年预测（按国家/地区划分）(%)
  • 英国生物技术市场收入及至2025年预测
    • 英国生物技术市场收入及至2025年预测
    • 英国生物技术市场收入及至2025年预测（依技术分类）
    • 英国生物技术市场收入及至2025年预测（按应用领域划分）
  • 德国生物技术市场收入及至2025年的预测
    • 德国生物技术市场收入及至2025年预测
    • 德国生物技术市场收入及至2025年预测（依技术分类）
    • 德国生物技术市场收入及至2025年预测（依应用领域划分）
  • 法国生物技术市场收入及至2025年预测
    • 法国生物技术市场收入及至2025年预测
    • 法国生物技术市场收入及至2025年预测（依技术分类）
    • 法国生物技术市场收入及至2025年预测（依应用领域划分）

第0章：亚太生物技术市场收入及至2025年预测

  • 概述
  • 亚太生物技术市场收入及至2025年预测
  • 亚太生物技术市场收入及预测（依技术划分）
  • 亚太生物技术市场收入及预测（按应用领域划分）
  • 亚太地区生物技术市场收入及至2025年预测（按国家/地区划分）(%)
  • 中国生物技术市场收入及至2025年预测
    • 中国生物技术市场收入及至2025年预测
    • 中国生物技术市场收入及至2025年预测（依技术分类）
    • 中国生物技术市场收入及至2025年预测（依应用领域划分）
  • 日本生物技术市场收入及至2025年预测
    • 日本生物技术市场收入及至2025年预测
    • 日本生物技术市场收入及至2025年预测（依技术分类）
    • 日本生物技术市场收入及至2025年预测（依应用领域划分）
  • 印度生物技术市场收入及至2025年预测
    • 印度生物技术市场收入及至2025年预测
    • 印度生物技术市场收入及至2025年预测（依技术分类）
    • 印度生物技术市场收入及至2025年预测（按应用领域划分）

第十一章：中东和非洲生物技术市场收入及至2025年预测

  • 概述
  • 中东及非洲生物技术市场收入及至2025年预测
  • 中东和非洲生物技术市场收入及预测（按技术划分）
  • 中东和非洲生物技术市场收入及预测（按应用领域划分）
  • 中东和非洲生物技术市场收入及至2025年预测（按国家/地区划分）
  • 阿联酋生物技术市场营收及至2025年预测
  • 阿联酋生物技术市场营收及至2025年预测
    • 阿联酋生物技术市场收入及至2025年预测（依技术分类）
    • 阿联酋生物技术市场收入及至2025年预测（依应用领域划分）
  • 沙乌地阿拉伯生物技术市场收入及至2025年预测
  • 沙乌地阿拉伯生物技术市场收入及至2025年预测
    • 沙乌地阿拉伯生物技术市场收入及至2025年预测（依技术分类）
    • 沙乌地阿拉伯生物技术市场收入及至2025年预测（按应用领域划分）
  • 南非生物技术市场收入及至2025年预测
  • 南非生物技术市场收入及至2025年预测
    • 南非生物技术市场收入及至2025年预测（依技术分类）
    • 南非生物技术市场收入及至2025年预测（依应用领域划分）

第十二章：南美洲和中美洲生物技术市场收入及至2025年的预测

  • 概述
  • 南美洲和中美洲生物技术市场收入及至2025年的预测
  • 南美洲和中美洲生物技术市场收入及预测（按技术划分）
  • 南美洲和中美洲生物技术市场收入及预测（按应用领域划分）
  • 南美洲和中美洲生物技术市场收入及至2025年预测（按国家/地区划分，百分比）
  • 巴西生物技术市场收入及至2025年预测
    • 巴西生物技术市场收入及至2025年预测
    • 巴西生物技术市场收入及至2025年预测（依技术分类）
    • 巴西生物技术市场收入及至2025年预测（依应用领域划分）

第十三章：生技市场－产业概况

  • 概述
  • 2016-2018年生物技术市场成长策略
  • 有机发展
    • 概述
  • 2016-2018年生物技术市场的有机成长策略
  • 产品发布
    • 生物技术市场参与者近期推出的产品
  • 产品认证
    • 生物技术市场参与者近期获得的产品批准
  • 扩充
    • 生物技术市场，依扩张区分
  • 无机发展
    • 概述
  • 2016-2018年生物技术市场无机成长策略
  • 合作伙伴关係
    • 生物技术市场参与者近期建立的合作关係
  • 协定
    • 生物技术市场（按协议划分）
  • 併购
    • 生物技术市场参与者近期併购活动

第十四章：生技市场－主要公司简介

  • THERMO FISHER SCIENTIFIC INC.14.1.1 Key Facts
  • MERCK KGAA
  • PERKIN ELMER, INC.14.3.1 Key Facts
  • AGILENT TECHNOLOGIES, INC.14.4.1 Key Facts
  • F.HOFFMANN-LA ROCHE LTD.14.5.1 Key Facts
  • DANAHER
  • QIAGEN
  • BD
  • BIO-RAD LABORATORIES, INC.14.9.1 Key Facts
  • ILLUMINA, INC.14.10.1 Key Facts

第十五章：附录

简介目录
Product Code: TIPHE100001316

The Biotechnology Market was valued at approximately US$ 427.17 billion in 2024 and is projected to reach US$ 966.68 billion by 2031, reflecting a compound annual growth rate (CAGR) of 12.6% during this period.

Biotechnology is utilized in various fields, including industrial bioprocessing, bioinformatics, food and agriculture, healthcare, natural resource management, and environmental conservation. Modern biotechnology fosters innovation by facilitating the creation of advanced products and technologies aimed at tackling rare and complex diseases, while also promoting sustainability through reduced environmental impact and enhanced food security.

Moreover, biotechnology contributes to cleaner and more energy-efficient industrial manufacturing processes. Key factors driving the market include the decreasing costs of genome sequencing, rapid technological advancements, and robust support from both private and public sector initiatives. The increasing number of industry conferences and workshops indicates a growing interest and investment in the sector, highlighting important market trends that are likely to influence ongoing growth.

Biotechnology Market Analysis

The significant drop in genome sequencing costs has been a major driver in the advancement of clinical genetics, transforming the diagnosis and treatment of rare diseases and accelerating the adoption of precision medicine. The cost of sequencing a human genome has plummeted from around $1 million in 2007 to $1,000 in 2014, and it currently stands at approximately $600.

This dramatic reduction has made genome sequencing more accessible, serving as a primary growth driver in the biotechnology market. Additionally, the increasing use of genomic technologies by pharmaceutical and biopharmaceutical companies is further propelling market growth, as these companies utilize sequencing data for drug discovery, targeted therapies, and personalized treatment strategies.

Biotechnology Market Overview

Experts in informatics and biology are increasingly employing advanced sequencing technologies to produce more accurate and comprehensive genomic data. Recent years have witnessed significant advancements in software for DNA assembly and innovative techniques for locating sequences on chromosomes, thereby enhancing genomic research capabilities.

To promote the adoption of these emerging technologies, several strategic initiatives have been launched. For instance, the National Human Genome Research Institute (NHGRI) initiated the Genome Sequencing Program in 1989 to capitalize on evolving opportunities in genomics. Concurrently, the Genome Technology Program is actively fostering the development of next-generation tools and instruments that facilitate rapid, cost-effective DNA sequencing, functional genomics experiments, and SNP genotyping. This program also aids in technology transfer from developers to end-users, encouraging multidisciplinary collaboration between academic and industrial research settings.

The market has also experienced a surge in innovation from industry players. Companies such as Pacific Biosciences (Sequel) and Oxford Nanopore Technologies (PromethION) have launched state-of-the-art next-generation sequencing (NGS) platforms. Meanwhile, systems like Roche GS FLX (454), Illumina HiSeq 2000 (Solexa), and AB SOLiD (Agencourt) continue to dominate the market. These technological advancements have significantly enhanced the speed, accuracy, and affordability of genome sequencing.

Consequently, ongoing innovations in sequencing technologies are anticipated to be a key driver of rapid growth in the biotechnology market throughout the forecast period.

The global biotechnology market is categorized by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America, particularly the US, represents the largest biotechnology market. Growth in this region is characterized by an increasing demand for innovative products from biopharmaceutical and biotechnology companies, the presence of major market players, and extensive R&D efforts by various academic and research institutions. Furthermore, continuous technological advancements are expected to further stimulate market growth in North America.

Strategic Insights

Biotechnology Market Drivers and Opportunities

Growing Emphasis on Advanced Methods in Healthcare to Benefit the U.S. Market

The biotechnology market in North America is experiencing rapid growth, driven by the integration of advanced technologies in healthcare, an increasing focus on precision medicine, and significant investments in genomic research from both public and private sectors. The region has become a center for biotechnological innovation, supported by collaborative efforts aimed at transforming healthcare delivery, enhancing agricultural productivity, and improving industrial biomanufacturing capabilities. Precision medicine, one of the most transformative trends in contemporary healthcare, is gaining substantial traction in the U.S. and Canada. Government-backed initiatives, along with venture capital and institutional funding, are propelling research into genomics, targeted therapies, and personalized diagnostics. This heightened focus is reshaping clinical practices and paving the way for tailored treatment regimens that offer improved efficacy and reduced side effects.

Both medical and agricultural biotechnology have seen significant advancements due to evolving research programs and adaptive business models. Bioengineering tools such as CRISPR, synthetic biology, and molecular diagnostics are being employed to create novel biomolecules, enhance disease resistance in crops, and develop next-generation therapeutic products. Notably, in 2022, the U.S. Department of Health and Human Services (HHS) allocated US$40 million to bolster biomanufacturing capacity for active pharmaceutical ingredients (APIs), antibiotics, and essential raw materials needed for producing critical medicines and enhancing pandemic preparedness. This investment addresses vital supply chain vulnerabilities and supports the onshoring of pharmaceutical production. Simultaneously, the U.S. Department of Defense (DoD) initiated the Tri-Service Biotechnology for a Resilient Supply Chain program, backed by over US$270 million over five years. This ambitious initiative aims to accelerate the commercialization of bio-based innovations, particularly in the defense sector, by developing sustainable fuels, high-performance materials, polymers, resins, and protective gear-elements crucial to national security and resilience.

These developments are further bolstered by a growing ecosystem of biotech companies, academic institutions, and innovation clusters in cities like Boston, San Francisco, and Toronto. Strong intellectual property frameworks, advanced research infrastructure, and a skilled workforce are also enhancing the region's global competitiveness. In summary, North America's biotechnology market is poised for sustained growth, driven by strategic investments, cutting-edge innovation, and government initiatives aimed at strengthening both healthcare and industrial resilience. This dynamic environment is expected to unlock significant economic value and solidify the region's leadership in the global biotechnology landscape over the forecast period.

Government Initiatives - An Opportunity for the Biotechnology Market

In December 2023, the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) announced the introduction of 14 new biotech-based products developed by start-ups and entrepreneurs across various sectors, including healthcare, diagnostics, medical devices, agriculture, and industrial biotechnology, during the 3rd edition of Global Bio-India, a major international biotechnology event held at Bharat Mandapam, Pragati Maidan in New Delhi.

Such advancements in recent years are likely to create attractive growth opportunities for the biotechnology market.

Biotechnology Market Report Segmentation Analysis

Key segments contributing to the Biotechnology Market analysis include product and application.

By product, the biotechnology market is divided into DNA sequencing, fermentation, cell-based assays, nanobiotechnology, chromatography, PCR technology, tissue engineering and regeneration, and other technologies. The DNA sequencing segment held the largest market share in 2023 and is expected to grow at the highest rate during the forecast period. DNA sequencing is a vital technique for determining the exact order of nucleotide bases within a DNA strand. It has become essential in both basic and applied research, with extensive applications in healthcare, biotechnology, agriculture, and forensic science.

One of the earliest large-scale applications of DNA sequencing was in the Human Genome Project, which lasted thirteen years and significantly advanced our understanding of genetic mutations associated with hereditary diseases. Today, DNA sequencing allows researchers to identify specific genes linked to genetic disorders, aiding in the development of targeted therapies and personalized medicine.

Beyond healthcare, DNA sequencing is widely utilized in genetic testing for paternity and familial relationships. It also plays a crucial role in forensic science, assisting in the identification of crime suspects and victims. In environmental contexts, DNA sequencing helps analyze bacteria and other microorganisms that contribute to air, water, and food contamination.

Additionally, this technology is vital in agricultural research, enabling scientists to study genetic variation and migratory patterns among animal and plant species. This information is essential for identifying rare breeds and optimizing seed and livestock development.

Overall, the versatility and impact of DNA sequencing continue to drive innovation and investment across various sectors.

Numerous companies, including Thermo Fisher Scientific Inc., Merck KGaA, Illumina, Inc., and various start-ups, provide a range of kits and reagents for DNA sequencing techniques. Thus, the benefits offered by DNA sequencing and its applications are expected to significantly boost the growth of this segment in the forecast period.

By application, the biotechnology market is segmented into industrial processing, bioinformatics, food & agriculture, health, natural resources & environment, and other applications. The industrial processing segment held the largest market share in 2023, while the bioinformatics segment is anticipated to grow at a faster rate during the forecast period. The industrial processing or bioprocessing market is one of the most promising areas of biotechnology, significantly impacting healthcare and agricultural biotechnology, and offering a new approach to pollution prevention and resource conservation. The industrial processing or bioprocessing market provides businesses with lower costs and creates new markets while minimizing environmental disruption. Most laboratory studies in biotechnology are conducted for commercial applications. These applications are utilized for drug discovery and development. Therapeutics for human proteins are developed through recombinant methods. For example, recombinant human insulin was the first recombinant medicine produced and marketed by Genentech in 1982. The rising prevalence of diabetes has led to substantial profits for recombinant insulin, contributing to significant future growth in the biotechnology market. Furthermore, industrial processing applications include the production of enzymes and microorganisms to create bio-based products in sectors such as chemicals, food ingredients, detergents, paper, textiles, beverages, fabrics, plastics, personal care, biofuels, and more.

Biotechnology Market Share Analysis by Geography

The geographic scope of the Biotechnology Market report is primarily divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America.

Asia Pacific is recognized as the fastest-growing region in the global biotechnology market. The market in this region is expected to experience significant growth in countries such as China, Japan, and India. This growth is attributed to the increasing focus of market players in developing economies and supportive government policies.

Biotechnology Market Report Scope

Biotechnology Market News and Recent Developments

The Biotechnology Market is assessed by collecting qualitative and quantitative data through primary and secondary research, which includes important corporate publications, association data, and databases. Below is a list of recent developments in the biotechnology market and strategies:

  • In April 2022, CytoTronics secured US$9.25M in initial seed funding, led by Anzu Partners, in collaboration with Milad Alucozai (BoxOne Ventures) and institutional investors. The company utilized this seed funding to advance its innovative platform that employs computer chip technology for conducting electrical and electrochemical cell-based assays (Source: CytoTronics, Press Release, 2022)

Biotechnology Market Report Coverage and Deliverables

The "Biotechnology Market Size and Forecast (2022-2030)" report offers a comprehensive analysis of the market covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles

Table Of Contents

1.INTRODUCTION

  • 1.1 SCOPE OF THE STUDY
  • 1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2.GLOBAL BIOTECHNOLOGY MARKET - KEY TAKEAWAYS

3.GLOBAL BIOTECHNOLOGY MARKET - MARKET LANDSCAPE

  • 3.1 OVERVIEW
  • 3.2 MARKET SEGMENTATION
    • 3.2.1 Global Biotechnology market - By Technology
    • 3.2.2 Global Biotechnology market - By Application
    • 3.2.3 Global Biotechnology market - By Geography
  • 3.3 PEST ANALYSIS
    • 3.3.1 North America - PEST Analysis
    • 3.3.2 Europe - PEST Analysis
    • 3.3.3 Asia Pacific - PEST Analysis
    • 3.3.4 Middle East and Africa - PEST Analysis
    • 3.3.5 South and Central America - PEST Analysis

4.GLOBAL BIOTECHNOLOGY MARKET - KEY MARKET DYNAMICS

  • 4.1 KEY MARKET DRIVERS
    • 4.1.1 Declining Prices of Genome Sequencing
    • 4.1.2 Increasing Innovative Technologies
    • 4.1.3 Increasing Number Of Initiatives By Private and Government Bodies
  • 4.2 KEY MARKET RESTRAINTS
    • 4.2.1 Risks Associated With Genetic Data
    • 4.2.2 Systemic Risks Of Genetically Modified Crops
  • 4.3 KEY MARKET OPPORTUNITIES
    • 4.3.1 Usage of NSG in Biomarker Discovery and Precision Medicine
  • 4.4 FUTURE TRENDS
    • 4.4.1 Rising Future Conferences and Workshops
  • 4.5 IMPACT ANALYSIS

5.BIOTECHNOLOGY MARKET - GLOBAL ANALYSIS

  • 5.1 GLOBAL BIOTECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS
  • 5.2 GLOBAL BIOTECHNOLOGY MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
  • 5.3 MARKET POSITIONING
  • 5.4 PERFORMANCE OF KEY PLAYERS
    • 5.4.1 Thermo Fisher Scientific, Inc.5.4.2 Danaher
  • 5.5 EXPERT OPINIONS

6.GLOBAL BIOTECHNOLOGY MARKET ANALYSIS - BY TECHNOLOGY

  • 6.1 OVERVIEW
  • 6.2 DNA SEQUENCING MARKET
    • 6.2.1 Overview
    • 6.2.2 Global DNA Sequencing Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.3 FERMENTATION MARKET
    • 6.3.1 Overview
    • 6.3.2 Global Fermentation Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.4 CELL BASED ASSAY MARKET
    • 6.4.1 Overview
    • 6.4.2 Global Cell Based Assay Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.5 NANOBIOTECHNOLOGY MARKET
    • 6.5.1 Overview
    • 6.5.2 Global Nanobiotechnology Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.6 CHROMATOGRAPHY MARKET
    • 6.6.1 Overview
    • 6.6.2 Global Chromatography Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.7 PCR TECHNOLOGY MARKET
    • 6.7.1 Overview
    • 6.7.2 Global PCR Technology Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.8 TISSUE ENGINEERING AND REGENERATION MARKET
    • 6.8.1 Overview
    • 6.8.2 Global Tissue Engineering And Regeneration Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.9 OTHERS MARKET
    • 6.9.1 Overview
    • 6.9.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn)

7.GLOBAL BIOTECHNOLOGY MARKET ANALYSIS - BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 INDUSTRIAL/BIO PROCESSING MARKET
    • 7.2.1 Overview
    • 7.2.2 Global Industrial/Bio Processing Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.3 BIOINFORMATICS MARKET
    • 7.3.1 Overview
    • 7.3.2 Global Bioinformatics Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.4 FOOD & AGRICULTURE MARKET
    • 7.4.1 Overview
    • 7.4.2 Global Food & Agriculture Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.5 HEALTH MARKET
    • 7.5.1 Overview
    • 7.5.2 Global Health Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.6 NATURAL RESOURCE & ENVIRONMENT MARKET
    • 7.6.1 Overview
    • 7.6.2 Global Natural Resource & Environment Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.7 OTHERS MARKET
    • 7.7.1 Overview
    • 7.7.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn)

8.NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 8.3 NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 8.4 NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 8.5 NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 8.6 US BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 8.6.1 US Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 8.6.2 US Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 8.6.3 US Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 8.7 CANADA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 8.7.1 Canada Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 8.7.2 Canada Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 8.7.3 Canada Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 8.8 MEXICO BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 8.8.1 Mexico Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 8.8.2 Mexico Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 8.8.3 Mexico Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 9.1 OVERVIEW
  • 9.2 EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 9.3 EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 9.4 EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 9.5 EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 9.6 UK BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.6.1 UK Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.6.2 UK Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 9.6.3 UK Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 9.7 GERMANY BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.7.1 Germany Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.7.2 Germany Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 9.7.3 Germany Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 9.8 FRANCE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.8.1 France Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.8.2 France Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 9.8.3 France Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

0.ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 0.1 OVERVIEW
  • 0.2 ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 0.3 ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 0.4 ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 0.5 ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 0.6 CHINA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 0.6.1 China Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 0.6.2 China Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 0.6.3 China Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 0.7 JAPAN BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 0.7.1 Japan Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 0.7.2 Japan Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 0.7.3 Japan Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 0.8 INDIA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 0.8.1 India Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 0.8.2 India Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 0.8.3 India Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

11.MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 11.1 OVERVIEW
  • 11.2 MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 11.3 MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 11.4 MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 11.5 MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN)
  • 11.6 UAE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 11.7 UAE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 11.7.1 UAE Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 11.7.2 UAE Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 11.8 SAUDI ARABIA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 11.9 SAUDI ARABIA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 11.9.1 Saudi Arabia Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 11.9.2 Saudi Arabia Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 11.10 SOUTH AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 11.11 SOUTH AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 11.11.1 South Africa Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 11.11.2 South Africa Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

12.SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 12.1 OVERVIEW
  • 12.2 SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 12.3 SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 12.4 SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 12.5 SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 12.6 BRAZIL BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 12.6.1 Brazil Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 12.6.2 Brazil Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 12.6.3 Brazil Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

13.BIOTECHNOLOGY MARKET - INDUSTRY LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 GROWTH STRATEGIES IN THE BIOTECHNOLOGY MARKET, 2016-2018
  • 13.3 ORGANIC DEVELOPMENTS
    • 13.3.1 Overview
  • 13.4 ORGANIC GROWTH STRATEGIES IN THE BIOTECHNOLOGY MARKET, 2016-2018
  • 13.5 PRODUCT LAUNCHES
    • 13.5.1 Recent Product Launches By Players In The Biotechnology Market
  • 13.6 PRODUCT APPROVALS
    • 13.6.1 Recent Product Approvals By Players In The Biotechnology Market
  • 13.7 EXPANSIONS
    • 13.7.1 The Biotechnology Market, By Expansions
  • 13.8 INORGANIC DEVELOPMENTS
    • 13.8.1 Overview
  • 13.9 INORGANIC GROWTH STRATEGIES IN THE BIOTECHNOLOGY MARKET, 2016-2018
  • 13.10 PARTNERSHIPS
    • 13.10.1 Recent Partnerships by Players in the Biotechnology Market
  • 13.11 AGREEMENTS
    • 13.11.1 The Biotechnology Market, By Agreements
  • 13.12 MERGERS AND ACQUISITIONS
    • 13.12.1 Recent Mergers and Acquisitions By Players In The Biotechnology Market

14.BIOTECHNOLOGY MARKET - KEY COMPANY PROFILES

  • 14.1 THERMO FISHER SCIENTIFIC INC.14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Financial Overview
    • 14.1.4 Product Portfolio
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 MERCK KGAA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Financial Overview
    • 14.2.4 Product Portfolio
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 PERKIN ELMER, INC.14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Financial Overview
    • 14.3.4 Product Portfolio
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 AGILENT TECHNOLOGIES, INC.14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Financial Overview
    • 14.4.4 Product Portfolio
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 F.HOFFMANN-LA ROCHE LTD.14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Financial Overview
    • 14.5.4 Product Portfolio
    • 14.5.5 Swot Analysis
    • 14.5.6 Key Developments
  • 14.6 DANAHER
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Financial Overview
    • 14.6.4 Product Portfolio
    • 14.6.5 Swot Analysis
    • 14.6.6 Key Developments
  • 14.7 QIAGEN
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Financial Overview
    • 14.7.4 Product Portfolio
    • 14.7.5 Swot Analysis
    • 14.7.6 Key Developments
  • 14.8 BD
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Financial Overview
    • 14.8.4 Product Portfolio
    • 14.8.5 Swot Analysis
    • 14.8.6 Key Developments
  • 14.9 BIO-RAD LABORATORIES, INC.14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Financial Overview
    • 14.9.4 Product Portfolio
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 ILLUMINA, INC.14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Financial Overview
    • 14.10.4 Product Portfolio
    • 14.10.5 Swot Analysis
    • 14.10.6 Key Developments

15.APPENDIX

  • 15.1 ABOUT THE INSIGHT PARTNERS
  • 15.2 GLOSSARY OF TERMS
  • 15.3 METHODOLOGY
    • 15.3.1 Coverage
    • 15.3.2 Secondary Research
    • 15.3.3 Primary Research 185